4,465 results on '"Lipton, Richard B."'
Search Results
202. Seizure self-prediction in a randomized controlled trial of stress management
203. Sex-specific norms for verbal memory tests may improve diagnostic accuracy of amnestic MCI
204. Naproxen for presymptomatic Alzheimer disease: Is this the end, or shall we try again?
205. Nativity differences in allostatic load by age, sex, and Hispanic background from the Hispanic Community Health Study/Study of Latinos
206. Differential association of left and right hippocampal volumes with verbal episodic and spatial memory in older adults
207. Abdominal obesity is a risk factor for dysexecutive function in chronic kidney disease
208. Recalled early life adversity and pain: the role of mood, sleep, optimism, and control
209. Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study
210. Lower inhibitory control interacts with greater pain catastrophizing to predict greater pain intensity in women with migraine and overweight/obesity
211. Interrelationships of Sleep Quality, Obesity Severity, and Clinical Headache Features among Women with Comorbid Migraine and Obesity
212. Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study
213. Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study
214. Age of first exposure to soccer heading: Associations with cognitive, clinical, and imaging outcomes in the Einstein Soccer Study
215. Predictors of treatment‐response to caffeine combination products, acetaminophen, acetylsalicylic acid (aspirin), and nonsteroidal anti‐inflammatory drugs in acute treatment of episodic migraine
216. Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials
217. Longitudinal assessment of comorbidities and co‐occurring conditions in adolescents with migraine: A secondary analysis of the National Longitudinal Study of Adolescent to Adult Health (Add Health)
218. OPTIMIZED ACUTE TREATMENT OF MIGRAINE IS ASSOCIATED WITH GREATER PRODUCTIVITY IN PEOPLE WITH MIGRAINE: RESULTS FROM THE CHRONIC MIGRAINE EPIDEMIOLOGY AND OUTCOMES (CAMEO) STUDY
219. Phase Ib, open‐label, fixed‐sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine
220. Test of Practical Judgment--Form B
221. Tracking cognition with the T‐MoCA in a racially/ethnically diverse older adult cohort
222. sj-pdf-1-cep-10.1177_03331024231180611 - Supplemental material for Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care
223. Additional file 1 of Availability of healthy foods, fruit and vegetable consumption, and cognition among urban older adults
224. Linking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative
225. Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability
226. Health-related Quality of Life, Cognitive Performance, and Incident Dementia in a Community-based Elderly Cohort
227. Spotlight on headache
228. Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
229. Sex differences in dementia risk and risk factors: Individual‐participant data analysis using 21 cohorts across six continents from the COSMIC consortium.
230. Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
231. Low eGFR is associated with dysexecutive and amnestic mild cognitive impairment
232. Comparison of “Word” vs. “Picture” version of the Free and Cued Selective Reminding Test (FCSRT) in older adults
233. Assessing Clinically Meaningful Treatment Effects in Controlled Trials: Chronic Migraine as an Example
234. Cluster Headache: Worse in Women
235. Concordance Between Logical Memory and Craft Story 21 in Community-Dwelling Older Adults: The Role of Demographic Factors And Cognitive Status
236. MRI‐guided Clustering of Alzheimer’s Disease patients: A post‐hoc analysis of Phase 3 Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
237. Perceived neighborhood safety and aesthetic quality are associated with cognitive change over time
238. Distinct Patterns of Brain Atrophy in MCR and amnestic MCI pre‐dementia syndromes
239. English language proficiency and patterns of use as related to cognitive change in native Spanish speakers of the Hispanics/Latinos of the Hispanic Community Health Study/Study of Latinos‐Investigation of Neurocognitive Aging
240. MRI Statistical region of interest best differentiates impaired from non‐impaired in the Study of Latinos‐Investigation of Neurocognitive Aging‐MRI (SOL‐INCA‐MRI)
241. Comparison of Plasma‐based Biomarkers and Cognitive Assessments in predicting progression of MCI to Dementia
242. Association of Cognition with Alcohol Consumption in Cognitively Unimpaired Older Adults: Results from the A4 study
243. Targeting the Correct Population for Trials: A Post‐hoc Analysis of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s disease.
244. Normative data for the Digit Symbol Substitution Test for diverse Hispanic/Latino adults: Results from the Study of Latinos‐Investigation of Neurocognitive Aging (SOL‐INCA)
245. Blood‐based biomarkers for neurodegeneration in non‐Hispanic Black and White older adults: Results from the Einstein Aging Study (EAS)
246. Connections between reproductive health and cognitive aging among women enrolled in the HCHS/SOL and SOL‐INCA
247. Assessing Risk of Incident Cognitive Impairment Using Stages of Objective Memory Impairment (SOMI) and Cerebrospinal Fluid
248. Cardiovascular health and resilience to cognitive decline and impairment among diverse Hispanics/Latinos: Results from the Study of Latinos‐ Investigation of Neurocognitive Aging (SOL‐INCA)
249. Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)
250. Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.